Funded Startups in Loos
Loos entries cluster around biotechnology and medical product themes: 3 of 5 companies are tagged Biotechnology (Lattice Medical on 2025-10-24 at $50M; GEN…
Loos entries cluster around biotechnology and medical product themes: 3 of 5 companies are tagged Biotechnology (Lattice Medical on 2025-10-24 at $50M; GENFIT on 2025-05-20 at $30M; Axorus on 2020-07-17 at $400K), with the remaining two split across Health Care (Axomove, 2026-04-22, $5M) and Energy (Energo, 2024-05-16, $18M). Disclosed round sizes also show a strong outlier pattern: the largest disclosed amount is Lattice Medical’s $50M (2025-10-24), which dwarfs the next-largest disclosed amount of $30M (GENFIT, 2025-05-20), and the smallest disclosed round is Axorus’s $400K (2020-07-17).
Temporally, the five rounds span 2020-07-17 to 2026-04-22, and 3 of the 5 entries fall in 2025 (Axomove is 2026-04-22; Lattice Medical and GENFIT are in 2025; Energo is 2024-05-16). Stage labeling is mixed: 2 of 5 entries are “Series Unknown” (GENFIT on 2025-05-20 at $30M; Energo on 2024-05-16 at $18M), while the rest specify Series A (Axomove, $5M) and Series B (Lattice Medical, $50M).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Loos, and how far above the next-largest disclosed amount is it?
Lattice Medical’s $50M (Series B, 2025-10-24) is the top disclosed amount in the five-row view, and it sits well above the next-largest disclosed round of $30M (GENFIT, Series Unknown, 2025-05-20). The gap is large enough that $50M also stands out versus all remaining disclosed amounts, including Energo’s $18M (2024-05-16) and Axomove’s $5M (2026-04-22).
Do the most recent Loos rounds cluster in a tight time window?
Yes: three of the five entries are in the 2024–2026 boundary, with two in 2025 (GENFIT on 2025-05-20 at $30M and Lattice Medical on 2025-10-24 at $50M) plus the latest entry in 2026 (Axomove on 2026-04-22 at $5M). The date range of disclosed rounds shown runs from 2020-07-17 (Axorus, $400K) to 2026-04-22 (Axomove, $5M).
Which sectors are over-represented among these Loos-funded companies?
Biotechnology is the dominant label, appearing in 3 of 5 companies: Lattice Medical ($50M, 2025-10-24), GENFIT ($30M, 2025-05-20), and Axorus ($400K, 2020-07-17). Health Care (Axomove, $5M on 2026-04-22) and Energy (Energo, $18M on 2024-05-16) each appear once.
How much of the stage information is missing in this list, and does it map to larger or smaller disclosed rounds?
Two of the five entries are labeled “Series Unknown” (GENFIT: $30M on 2025-05-20; Energo: $18M on 2024-05-16). Those unknown-stage rounds sit in the upper-middle of the disclosed range, above Axomove’s $5M (Series A, 2026-04-22) and far above Axorus’s $400K (2020-07-17), while Lattice Medical is the only disclosed Series B ($50M on 2025-10-24).
Is there a meaningful outlier by size or by sector within these five Loos rows?
Size-wise, Axorus ($400K on 2020-07-17) is the clear low-end outlier, while Lattice Medical ($50M on 2025-10-24) is the high-end outlier. Sector-wise, the most consistent theme is Biotechnology (three entries across multiple years), but the Energy outlier (Energo at $18M on 2024-05-16) breaks the biotech concentration without matching the top $30M–$50M cluster.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.